ChinaBulls
Request access
Close

Peijia Medical (Suzhou) Co., Ltd.沛嘉医疗

Biotech/Healthcare

Peijia Medical's TaurusOne has completed clinical trials and is expected to obtain medical device registration and launch in 2020. The company is developing its second-generation aortic valve product as well as mitral and tricuspid valve products, which will soon enter the clinical stage.

Source: ChinaBulls — chinabulls.com

Last updated 2020-05-01

Funding Rounds

  • IPO
    RaisedFunding amount requires an account.

    Create Account to Unlock Full Data for Free

    SIGN UP

Peijia Medical (Suzhou) Co., Ltd. Fundraising Info

Company fundraising information requires an account.

Peijia Medical (Suzhou) Co., Ltd. Investors and Backers

Unlock Full Data for Free

Get access to market data, insights, backers, analytics and funding rounds.

SIGN UP